Preparation of patients with haemostasis disorder for dental surgery

Česká verzia

Authors: O. Bulik ¹; A. Buliková ²; P. Smejkal ²; M. Penka ²
Authors place of work: Klinika ústní, čelistní a obličejové chirurgie Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Milan Machálka, CSc. ¹; Oddělení klinické hematologie FN Brno, pracoviště Bohunice, prim. prof. MUDr. Miroslav Penka, CSc. ²
Published in the journal: Vnitř Lék 2008; 54(4): 415-420
Category: Review

Předneseno na XIII. Pařízkových dnech s mezinárodní účastí s podtitulem Diagnostika a léčba krvácení v praxi, konaných v Novém Jičíně ve dnech 15. 16. 3. 2007.

Summary

The most of patients need dental care during their time of life. It can be situation to detect bleeding disorder in patients who have been suggested apparently healthy to this time. In patients with known bleeding tendency it can be situation in which good interdisciplinary coordination is necessary. In the most cases patients with anticoagulation treatment are involved between those with haemostasis problems. Nevertheless, they do not need therapy interruption in the most of cases, only the knowing actual therapeutic level of INR and appropriate stomatologistʼs erudition. Another situation is in patients with severe haemostatic bleeding disorder. They don’t need only special procedure in dental extractions but also lifelong dental care. One can establish patients, in whom it is not possible only outpatient treatment but in whom a few days hospitalization is necessary. Above all they are patients with haemophilia and inhibitor, those with multiple or surgery extractions and persons with multiple haemostasis impairment.

Key words:
dental care – bleeding disorder – anticoagulant treatment

Zdroje

1. Miloro M. Petersonʼs Principles of Oral and Maxillofacial surgery. 2nd ed. Hamilton - London: BC Decker 2004.

2. Moore JR. Surgery of the Mouth and Jaws. Oxford: Blackwell Scientific Publications 1985.

3. Harrington B. Primary dental care of patients with haemophilia. Haemophilia 2000; 6(Suppl 1): 7–12.

4. Shinton NK. Standardisation of oral anticoagulant treatment. Br Med J 1983; 287: 1000–1001.

5. Weibert RT. Oral anticoagulant therapy in patients undergoing dental surgery. Clin Pharm 1992; 11: 857–864.

6. Roser SM, Rosenbloom B. Continued anticoagulant in oral surgery procedures. Oral Surg Oral Med Oral Pathol 1975; 40: 448–457.

7. Spandorfer JM, Lynch S, Witz HH et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84: 478–480.

8. Bailey BMW, Fordyce AM. Complications of dental extractions in patients receiving warfarin anticoagulant therapy – a controlled clinical trial. Br Dent J 1983; 155: 308–310.

9. Sindet-Pedersen S, Ramström G, Bernvil S et al. Hemostatick effect of tranexamic acid mouthwash in anticoagulant – treated patients undegoing oral surgery. N Engl J Med 1989; 320: 840–843.

10. Martinowitz U, Mazar AL, Taicher S. Dental extraction for patients on oral anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1990; 70: 274–277.

11. Borea G, Montebugnoli L, Capuzzi P et al. Tranexamic acid as a mouthwash in anticoagulant treated patients undergoing oral surgery. Oral Surg Oral Med Oral Pathol 1993; 75: 29–31.

12. Devani P, Lavery KM, Howell CJT. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Brit J Oral Maxillofac Surg 1998; 36: 107–111.

13. Blinder D, Manor Y, Martinowith U et al. Dental extractions in patients maintained on continued oral anticoagulant. Oral Surg Oral Med Oral Pathol Radiol Endod 1999; 88: 137–140.

14. Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 1995; 74: 482–485.

15. Russo G, Dal Corso L, Biasiolo A et al. Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures. Clin Appl Thromb Hemost 2000; 6: 90–93.

16. Behrman SJ, Wright IS. Dental surgery during continuous anticoagulant therapy. J Am Dent Assoc 1961; 62: 172.

17. Mahrshall J. Rebound phenomena after anticoagulant therapy in cerebrovascular disease. Circulation 1963; 28: 329.

18. Ogiuchi H, Ando T, Tanaka M. Clinical reports on dental extraction from patients undergoing oral anticoagulant therapy. Bull Tokyo Dent Coll 1985; 26: 205.

19. Johnson WT, Leary JM. Management of dental patients with bleeding disorders: review and update. Oral Surg Oral Med Oral Pathol 1988; 66: 297–303.

20. Robbins RC, Bowman FO, Malm JR. Cardiac valve replacement in children: a twenty – year series. Ann Thorac Surg 1998; 45: 56–61.

21. Mulligan R. Response to anticoagulant drug withdrawal. J Am Dent Assoc 1987; 115: 435–438.

22. Bulik O. Extrakce zubů a antikoagulační terapie – srovnání různých postupů. Prakt Zubn Lek 2004; 52; 68–77.

23. Gaspar R, Brenner B, Ardekian L et al. Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication. Quintessence Int 1997; 28: 375–379.

24. Bodner L, Weinstein JM, Baumgartner AK. Efficacy of fibrin sealant in patients on various levels of oral anticoagulant undergoign oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 421–424.

25. Martinowitz U, Schulman S. Fibrin sealant in surgery of patients with a hemorrhagic diathesis. Thromb Haemost 1995; 74: 486–492.

26. Sindet-Pedersen S, Stenbjerg S Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg 1986; 44: 703–707.

27. Sindet-Pedersen S, Stenbjerg S, Ingerslev J. Control of gingival haemorrhage in hemophilic patients by inhibition of fibrinolysis with tranexamic acid. J Periodont Res 1988; 23: 72–74.

28. Sindet-Pedersen S. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: A pharmacokinetic study. J Clin Pharmacol 1987; 27: 1005–1008.

29. Sindet-Pedersen S, Gram J, Jespersen J. Characterization of plasminogen activators in unstimulated and stimulated human whole saliva. J Dent Res 1987; 66: 1119.

30. Souto JC, Oliver A, Zuazu-Jausoro I et al. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 1996; 54: 27–32.

31. Halfpenny W, Fraser JS, Adlam DM. Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 257–259.

32. Rakocz M, Mazar A, Varon D et al. Dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol. 1993; 75: 280–282.

33. Ansell J, Hirsh J, Poller L et al. The pharmacology and management of the vitamin K antagonists. The seventh ACCP conference on antithrombotic and thromoblytic therapy. Chest 2004; 126: 204S–233S.

34. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition – 2005 update. British J Haematol 2005; 132: 277–285.

35. Franchini M, Rossetti G, Tagliaferri A et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centres. Haemophilia 2005; 11: 504–509.

36. Brewer AK, Roebuck EM, Donachie M et al. The dental management of adult patients with haemophilia and other congenital bleeding disorders. Guideline. Haemophilia 2003; 9: 673–677.

37. Hemophilia of Georgia, USA: Protocols for the treatment of haemophilia and von Willebrand disease. Haemophilia 2000; 6(Suppl 1): 84–93.

38. Scully C, Dios PD, Giagrande P et al. Oral care for people with hemophilia or a hereditary bleeding tendency. In treatment of hemophilia; World Federation of hemophilia, Montreal 2002; 1–10.

39. Sindet-Pedersen S. Oral bleeding. In: Forbes CD, Aledort L Madhok H (eds). Hemophilia. London: Chapman and Hall 1997: 103–113.

40. Arnold DM, Crowther MA, Cook RJ et al. Utilisation of platelet transfusion in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion 2006; 46: 1286–1291.

41. British committee of standards in haematology, blood transfusion task force: Guideline for the use of platelet transfusion. Br J Haematol 2003; 122: 10–23.

42. Brand A. Transfusion support in malignant diseases. In: Heier HE, Turek P, Walterová L (eds). Clinical transfusion medicine. Liberec 2006: 67–75.

43. Poon MC, dʼOiron R, von Depka M et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmannʼs thrombastenia: results of an international survey. J Thromb Haemost 2004; 2: 1096–1103.

44. Bournias M, Katsarou O, Kouraba A et al. Dental surgery in patients with bleeding disorders: results from five years practice (2000–2005). Haemophilia 2006; 12(Suppl 2): 34–36.